Skip to main content
. 2018 Apr 5;7(2):31. doi: 10.3390/antibiotics7020031

Table 4.

Oligonucleotide primers employed for DNA sequence analysis and plasmid constructions.

Name λ Map Position Sequence (5′ to 3′) a
L-37904+18 37904–37922 GCTGCTCTTGTGTTAATGG
L-MH29 37905–37922 CGTCCTCAAGCTGCTCTTGTGTTAATGG
L20 39465–39484 ACTCCGCGATAAGTGGACCC
L-22 38517–38534 TGCTGCTTGCTGTTCTTG
L-PG30 38530–38547 TTGGAACTGAGAAGACAG
L-PG1 38784–38801 AAATATGCTGCTTGAGGC
L-38985p20 38985–39005 GCAGCAAGGCGGCATGTTTGG
L-MH32 39531–39550 CACAGATCTATAGCAAACCAAAACTCGACCTGA
L-18 39980–39996 TTGCCGGAAGCGAGGCC
L-21 40360–40377 CGCAACAGTAACCAGCAT
R-PG2 40747–40764 GGTTGCGTTCCTGAATGG
L-Bam-O 38686–38718 ATATGGATCCATGACAAATACAGCAAAAATACTCAACTTCGGC
L-Bam-P 39582–39606 ATATGGATCCATGAAAAACATCGCCGCACAGATGG
L-Bam-OOP#1 38559–38580 ATATGGATCCTGGCTCGATTGGCGCGACAAGT
L-Bam-OOP#2 38546–38577 ATATGGATCCGTTGACGACGACATGGCTCGAT
L-Bam-O 38686–38718 ATATGGATCCATGACAAATACAGCAAAAATACTCAACTTCGGC
L-Bam-P 39582–39606 ATATGGATCCATGAAAAACATCGCCGCACAGATGG
R-40769m22 40747–40769 GCTGCGGTTGCGTTCCTGAATGG
R-MH33 40315–40295 GCGACGTCCCCAGGTAATGAATAATTGC
R-17 40018–40002 TAAGACTCCGCATCCGG
R-MH25 39626–39609 CTGCTCACGGTCAAAGTT
R-39280m21 39259–39280 CTGCGGCGGTCAGGTCTTCTGC
R9+1 39191–39175 TGGTCAGAGGATTCGCC
R-PG6 38569–38552 CAATCGAGCCATGTCGTC
R-1536-19 pcIpR-()-timm GAAGACAGTCATAAGTGCGG
R-ClaI-P 40280–40259 ATATATCGATTATACACTTGCTCCTTTCAGTCCG
R-ClaI-O 39582–39559 ATATATCGATTATAGATCCACCCCGTAAATCCAGTC
R-ClaI-36P 39687–39662 ATATATCGATTACCTGCTGTACCTGCGGCTTTTCGTCG
R-ClaI-63P 39768–39746 ATATATCGATTACTTCGTTCTGGTCACGGTTAGCC
R-AscI-O 39582–39559 ATATGGCGCGCCGCTGCCGCCTAGATCCACCCCGTAAATCCAGTC

a The portion of primer sequences shown in smaller font size contain restrictions sites used for cloning into plasmids and are not included within λ map sequence shown.